Edwin Urrutia is the Co-Founder & Chief Operating Officer at Pyros Pharmaceuticals since May 2017. Edwin is also the Co-Founder at Phoenixus AG since October 2014 and holds the title of Vice President at Travere Therapeutics since November 2013. Prior to their current roles, Edwin worked as an Analyst at Piper Sandler starting from July 2011. Edwin Urrutia obtained their Bachelor's Degree in Finance from Northeastern University.
